Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Saved in:
| Title: | Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). |
|---|---|
| Authors: | Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group (CORPORATE AUTHOR), ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (CORPORATE AUTHOR) |
| Source: | JAMA: Journal of the American Medical Association. 12/18/2002, Vol. 288 Issue 23, p2981-2997. 17p. |
| URL: | 8688392 |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
